Advances in counselling and surveillance of patients at risk for pancreatic cancer

Gut

Volumn 56, Issue 10, 2007, Pages 1460-1469

  Brand, Randall E ^a,b   Lerch, Markus M ^c   Rubinstein, Wendy S ^b   Neoptolemos, John P ^d   Whitcomb, David C ^e   Hruban, Ralph H ^f   Brentnall, Teresa A ^g   Lynch, Henry T ^h   Canto, Marcia I ^f   Andren Sandberg, Ake ^a   Lowenfels, Al ^a   Kammesheidt, Anja ^a   Newlin, Anna ^a   Tribe, Barbara ^a   Korczowski, Bartosz ^a   Elinoff, Beth ^a   Krishnamachari, Bhuma ^a   Edelstein, Brian ^a   Ulrich, Charles ^a   McFaul, Christopher ^a   Johnson, Cohn ^a   Louqueeker, Daniel S ^a   Claude, Ferec ^a   Fortunato, Franco ^a   Weiss, Frank Ulrich ^a   Michael, Hazar ^a   Rothenmund, Heidi ^a   Ellis, Ian ^a   Grendell, James H ^a   Ledford, Jeff ^a   Kart, Jeffrey ^a   Mossuer, Joachim ^a   Emmrich, Joerg ^a   Rommens, Johanna ^a   Martin, John A ^a   Kleeff, Jorg ^a   Montgomery, Laura ^a   Olpinski, Marian ^a   Pelaez Luna, Mario ^a   Lerch, Markus ^a   Fesinmeyer, Megan Dann ^a   Wilschanski, Michael ^a   Sahin Toth, Miklos ^a   Hanaway, Patrick ^a   Maisonneove, Patrick ^a   Simon, Peter ^a   Nguyen, Phithao ^a   Brand, Randall ^a   Sutton, Robert ^a   Wong, Robert ^a   Connor, Saxon ^a   Weissman, Scott ^a   Hahn, Stephen ^a   Waterford, Stephen ^a   Keiles, Steven ^a   Griesbacher, Thomas ^a   Shimosegawa, Tooru ^a   Hlouschek, Verena ^a   more..

^a Evanston Northwestern Healthcare ^*

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h CREIGHTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; DIAGNOSTIC IMAGING; GENE INTERACTION; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; OBESITY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOM;

EARLY DIAGNOSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; PANCREATIC NEOPLASMS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 34948870763     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.108456     Document Type: Review

References (88)

1. American Cancer Society. Cancer Facts & Figures 2006. Atlanta: ACS, 2006.
2. Ferlay J, Bray F, Pisani P, et al. Globocan 2000: cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC CancerBase No. 5. Lyons: IARC Press, 2001.
3. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitits: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1:405-15.
4. Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 2001;1:416-42.
5. Schneider G, Schmid RM. Genetic alterations in pancreatic carcinoma. Mol Cancer 2003;2:15-21.
6. Hruban RH, Wilentz RE, Kern SE. Genetic progression in the pancreatic ducts. Am J Path 2000;156:1821-25.
7. Maitra A, Fukushima N, Takaori K, et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol 2005;12:81-91.
8. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-21.
9. Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766-81.
10. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 1998;7:67-91.
11. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA Cancer J Clin 2000;50:241-68.
12. Michaud DS, Giovannucci E, Willet WC, et al. Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 2001;10:429-37.
13. Velema JP, Walker AM, Gold EB. Alcohol and pancreatic cancer. Insufficient epidemiologic evidence for a causal relationship. Epidemiol Rev 1986;8:28-41.
14. Villeneuve PJ, Johnson KC, Hanley AJ, et al. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced Surveillance System case-control project. Canadian Cancer Registries Epidemiology Research Group. Eur J Cancer Prev 2000;9:49-58.
15. Norton ID, Petersen BT, Miller IJ, et al. Frequency of a family history of pancreatic malignancy in patients with pancreatic malignancy. Pancreas 1998;17:451.
16. Brand RE, Lynch HT. Hereditary pancreatic adenocarcinoma: a clinical perspective. In: Whitcomb DC, Cohn JA, Ulrich CD, eds. The Medical Clinics of North America: inherited diseases of the pancreas. Pennsylvania: W, B.Saunders Co, 2000;84:665-75.
17. Lichenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
18. Lynch HT, Fitzsimmons ML, Smyrk TC, et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990;85:54-60.
19. Lynch HT, Voorhees GJ, Lanspa SJ, et al. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 1985;52:271-3.
20. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 1991;6:127-31.
21. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6.
22. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252-61.
23. Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002;94:1365-72.
24. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-16.
25. Goldstein AM, Fraser MC, Struewing JP, et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995;333:970-4.
26. Su GH, Hruban RH, Bansal RK, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-40.
27. Wang F, Herrington M, Larsson J, et al. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003;2:4.
28. Guillo L, Pezzilli R, Morselli-Labate AM, et al. Diabetes and the risk of pancreatic cancer. NEJM 1994;331:81-4.
29. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995;273:1605-9.
30. Silverman DT, Schiffman M, Everhart J, et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-7.
31. Chari ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 2005;129:504-11.
32. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-7.
33. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology 1995;10:247-51.
34. Karlson BM, Ekbom A, Josefsson S, et al. The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology 1997;113:587-92.
35. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002;51:849-52.
36. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001;93:937-41.
37. Maisonneuve P, FitzSimmons SC, Neglia JP, et al. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 2003;95:381-7.
38. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004;64:2634-8.
39. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PloS Medicine 2004;1e65:229-36.
40. Vasen HFA, Gruis NA, Frants RR, et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-LEIDEN). Int J Cancer 2000;87:809-11.
41. Borg A, Sandberg T, Nilsson K, et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000;92:1260-6.
42. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastro 2000;119:1447-53.
43. Neglia JP, Fitzsimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995;332:494-9.
44. Talamini G, Falconi M, Bassi C, et al. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 1999;94:1253-60.
45. Fernandez E, La Vecchia C, Porta M, et al. Pancreatitis and the risk of pancreatic cancer. Pancreas 1995;11:185-9.
46. Lal G, Liu G, Schmocker B, et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1 and BRCA2 mutations. Cancer Res 2000;60:409-16.
47. van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, et al. Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 2005;42:711-19.
48. Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003;95:214-21.
49. Martin ST, Matsubayashi H, Rogers CD, et al. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene 2005;24:3652-6.
50. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Rse 2002;62:3789-93.
51. Couch FJ, Johnson MR, Rabe KG, et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2007;16:342-6.
52. van der Heijden MS, Yeo CH, Hruban RH, et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003;63:2585-8.
53. Couch FJ, Johnson MR, Rabe K, et al. Germ lime Fanconi anemia complementation group C mutations and pancreatic cancer. Cancer Res 2005;65:383-6.
54. Lynch HT, Deters CA, Snyder CL, ef al. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships. Cancer Genet Cytogenet 2005;158:119-25.
55. Thompson D, Easton DF, et al. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-65.
56. Pogue-Geile KL, Chen R, Bronner MP, et al. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism. PLOS Medicine 2006;3:e516.
57. Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-70.
58. Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001;93:640-4.
59. Rulyak SJ, Lowenfels AB, Maisonneuve P, et al. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003;124:1292-9.
60. Michaud DS, Giovannucci E, Willet WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001;286:921-9.
61. Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 2005;93:1062-67.
62. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet 2004;363:1049-57.
63. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:721-31.
64. Ariyama J, Suyama M, Satoh K, et al. Imaging of small pancreatic ductal adenocarcinoma. Pancreas 1998;16:396-401.
65. Egawa S, Takeda K, Fukuyama S, et al. Clinicopathological aspects of small pancreatic cancer. Pancreas 2004;28:235-40.
66. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-10.
67. Parks RW, Garden OJ. Ensuring early diagnosis in pancreatic cancer. Practitioner 2000;244:336-43.
68. Barkin JS, Goldstein JA. Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother 2000;54:400-9.
69. DiMagno EP, Malagelada JR, Taylor WP, et al. A prospective comparison of current diagnostic tests for pancreatic cancer. N Engl J Med 1977;97:737-42.
70. Krech RI, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991;6:360-7.
71. Kim JE, Lee KT, Lee JK, et al. Clinical usefulness of carbohydrate antigen CA 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 2004;19:182-6.
72. Malesci A, Montorsi M, Mariani A, et al. Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study. Pancreas 1992;7:497-502.
73. Brand R. The diagnosis of pancreatic cancer. Cancer J 2001;7:287-97.
74. Brentnall TA, Bronner MP, Byrd DR, et al. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-55.
75. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001;1:477-85.
76. Kimmey MB, Brentnall TA, Bronner MP, et al. Endoscopic ultrasound screening for familial pancreatic cancer. Gastrointest Endosc 2002;56:S82-6.
77. Bhutani MS. Endoscopic ultrasonography: changes of chronic pancreatitis in asymptomatic and symptomatic alcoholic patients. J Ultrasound Med 1999;18:455-62.
78. Simon P, Lerch MM. Endoscopic evaluation and management of hereditary pancreatitis. Tech Gastrointest Endosc 2004;6:115-21.
79. Choudari CP, Nickl NJ, Fogel E, et al. Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy. Gastrointest Endosc 2002;56:66-71.
80. Axilbund JE, Brune KA, Canto MI, et al. Patient perspective on the value of genetic counseling for familial pancreas cancer. Hered Cancer Clin Pract 2005;3:115-22.
81. American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003;21:2397-406.
82. Weber B. Breast cancer susceptibility genes: current challenges and future promises. Ann Intern Med 1996;124:1088-90.
83. Simon P, Weiss FU, Zimmer KP, et al. Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA 2002;288:2122.
84. Mills PK, Beeson WL, Abbey DE, et al. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988;61:2578-85.
85. Nothlings U, Wilkens LR, Murphy SP, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst 2005;97:1458-65.
86. Skinner HG, Michaud DS, Giovannucci E, et al. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006;15:1688-95.
87. Yan L, McFaul C, Howes N, et al. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology 2005;128:2124-30.
88. McFaul C, Greenhalf W, Earl J, et al. Anticipation in familial pancreatic cancer. Gut 2006;55:252-8.